News

Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

ISB’s Dr. Lee Hood presented the PMWC Luminary Award to Dr. Anthony Fauci on Monday, and the two renowned scientists engaged in an interesting hour-long conversation. 

The Luminary Award was presented on behalf of Precision Medicine World Conference on the first day of PMWC COVID, a three-day virtual event. The award recognizes contributions of prominent figures who have accelerated personal medicine to the clinic.

Hood spoke with Fauci, director of the National Institute of Allergy and Infectious Disease, about a number of topics, including the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19 and the technology’s promise for creating effective vaccines for other diseases (including some cancers), lessons learned from the COVID-19 pandemic, and more. 

“We should have a vaccine, as well as universally applicable antivirals, that we could use for the next outbreak,” Fauci said. “I would be really disappointed if when this is over we don’t put together a commission and codify what we need to do as opposed to saying ‘well, we got through that, now let’s worry about the next problem’.”

You can watch the conversation here or by playing the video above.

Recent Articles

  • Bringing DNA Sequencing to the High School Classroom

    Christopher Lausted and Dr. Danielle Vermaak were featured guests of an ISB Research Roundtable presentation. The husband-and-wife team detailed the planning and rollout of a DNA sequencing curriculum project that was tested in Vermaak’s Lincoln High School science classroom in Seattle.

  • Risk Factors for Severe COVID-19 in Hospitalized Adults Differ by Age

    A just-published study provides new information about which hospitalized COVID-19 patients are most likely to need mechanical ventilation or to die. The ISB-led work shows that vital signs and lab results at the time of hospital admission are the most accurate predictors of disease severity, more so than comorbidities and demographics.

  • Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

    Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.